Tubeless Insulin Pumps Segmentation
Component (Patch/Pod, Remote, Accessories)
The insulin patch/pod segment in the tubeless insulin pump market accounted for the largest share and it is expected to retain its position during the forecast period. The growth of the patch pump segment can be attributed to its ease of use as it can be attached to the skin with minimal supervision for blood glucose management. Due to their user-friendly nature, they are fast replacing the traditional syringe combinations and facilitating the growth of this segment. In January 2024, Embecta Corp. announced the submission of an FDA 510 (k) for an insulin patch pump.
The remote segment is rapidly growing due to the integration of tubeless insulin pumps with smartphones. The ability to administer insulin delivery without direct contact with the device fosters better convenience for the users. The focus on convenience is boosting the growth of this segment.
End use (Hospitals, Pharmacies, e-commerce, Others)
Based on end-use, the hospitals segment had the highest tubeless insulin pump market share in 2023 owing to the rising awareness and technical insights on advanced diabetic care in hospitals and improving healthcare infrastructure. The availability of skilled healthcare professionals and a large number of hospital admissions requiring diabetic care are also expected to drive segment revenue growth during the forecast period.
Our in-depth analysis of the global tubeless insulin pump market includes the following segments:
|
Component |
|
|
Type
|
|
|
End use |
|
